HCS Pharma is a CRO specialized in cell imaging (HCA/HCS) that offers services (phenotypic screening, efficacy and safety assays, POC) in pre-clinical in vitro research. Expertise: the development of new in vitro tests in pharmacology and their use in medium / high throughput screening in cell imaging: “High Content Analysis” (HCA) / “High Content Screening” (HCS). Its areas of expertise: neurodegenerative diseases (Parkinson, Alzheimer, …), oncology, toxicology (hepatotoxicology …).